Laura Coates
0000-0002-4756-663X
Oxford University
76 papers found
Refreshing results…
Prevalence of Psoriatic Arthritis Patients Achieving Minimal Disease Activity in Real-world Studies and Randomized Clinical Trials: Systematic Review with Metaanalysis
Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study
GRAPPA 2018 Project Report
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
The Role of Ultrasound in Psoriatic Arthritis — Do We Need a Score?
Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis?
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase-III Study
Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity
Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial
Remission in psoriatic arthritis—where are we now?
Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen
Missing publications? Search for publications with a matching author name.